Anti-Viral Drugs Market with Current Trends Analysis, 2016-2026 Anti-Viral Drugs Market with Current Trends Analys | Page 3

Report
Description
Report Description
Anti-viral drugs are medicines which are used specially for treating viral infections. Most
anti-viral drugs are used for particular viral infections, similar to antibiotics, while a
broad-spectrum anti-viral drug is effective against a varied range of viruses. Antiviral
drugs do not kill their target pathogen, instead they inhibit the development of those
viruses. The global anti-viral drugs market is projected to register a moderate growth rate
in the pharmaceutical market and which is anticipated to increase due to rise in
awareness level, increase in the diseased population and introduction of new drugs with
improved efficacy. Some major patents are reaching their expiry during forecast period,
such as for Combivir, Sustiva, Tenofovir, Tamiflu, Relenza and Telbivudine. The patent
expiries of these blockbuster drugs is expected to trigger generic competition in the
antivirals therapeutics market, which will make the market more competitive. The late
stage pipeline drugs are expected to enter the market, which will positively impact the
market. Most antivirals are considered comparatively harmless to host, and therefore are
used to treat infections. They are different from viricides, which are not used for
medication but can destroy or deactivate virus particles, either outside or inside the
body. The anti-viral drugs are used in the treatment of patients suffering from herpes
viruses, HIV, influenza A and B viruses and the hepatitis B and C viruses.
Request Free Report Sample@
http://www.futuremarketinsights.com/reports/sample/rep-gb-1951